X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Clinical Breast Cancer

期刊標題檢索 CLIN BREAST CAN 最新評論: After being under review for several months, it was accepted when I sa... (2024-01-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Clinical Breast Cancer]您好,您是該頁面的第 25068 位訪客。

期刊簡介
期刊名稱Clinical Breast Cancer Clinical Breast Cancer
LetPub Score
6.2
50 ratings
Rate

Reputation
7.6

Influence
5.0

Speed
7.0

期刊簡稱CLIN BREAST CANCER
ISSN1526-8209
E-ISSN1938-0666
h-index64
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.400.9420.844
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2151 / 404
Category: Medicine
Subcategory: Cancer Research
Q3125 / 230

自引率 (2023-2024)3.40%自引率趨勢
掲載範囲
Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.
官方網站http://www.journals.elsevier.com/clinical-breast-cancer
在線稿件提交https://www.editorialmanager.com/CBC
開放訪問No
出版商Elsevier
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年2000
每年文章數140每年文章數趨勢
黃金OA百分比12.30%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ2151/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1526-8209%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 3 Month(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【Clinical Breast Cancer】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326312
    CANCER RESEARCH310968
    BMC CANCER242833
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197880
    INTERNATIONAL JOURNAL OF CANCER188283
    Asian Pacific Journal of Cancer Prevention184792
    CLINICAL CANCER RESEARCH180958
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171664
    ONCOLOGY REPORTS171248
    CA-A CANCER JOURNAL FOR CLINICIANS163265
  •  

    Clinical Breast Cancer Clinical Breast Cancer
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Clinical Breast Cancer] 的評論撰寫評論
作者: 东海楚恒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-06 10:03:37 評論於
After being under review for several months, it was accepted when I saw it again
(0) 讚! | 东海楚恒

作者: 削月天成


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-21 18:24:18 評論於
Your article has not had any updates for a month, what is the status of it, my w i t h e d i t o r?
(0) 讚! | 削月天成

作者: 削月天成


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-20 12:51:40 評論於
Do I need everyone to click on the link too, or just me with editor after a month?
(0) 讚! | 削月天成

作者: 七伤寒蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-25 09:54:28 評論於
What suggestions did Xiao Xiu make? Mine only made changes to the images
(0) 讚! | 七伤寒蕊

作者: 七伤寒蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-25 08:49:30 評論於
Hello, may I ask what did Xiaoxiu do to still get rejected?
(0) 讚! | 七伤寒蕊

作者: 东海楚恒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-19 22:13:18 評論於
If you can choose not to use OA, then it won't cost anything
(0) 讚! | 东海楚恒

作者: 东海楚恒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-11 19:17:58 評論於
Cannot reach the editor
(0) 讚! | 东海楚恒

作者: 东海楚恒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-31 17:50:03 評論於
Research Emphasis: Clinical; Breast Cancer
Experience Share: Submitted an article to SEER at the end of April, but did not receive any updates midway. Contacted the journal, and was informed that they couldn't find any reviewers. Received an email at the end of July, and the article was accepted directly with no revisions!
(0) 讚! | 东海楚恒

作者: 黑山天韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-29 14:56:00 評論於
Review Speed: 6.0 Experience Sharing: My article on the official website is marked as "revised," but there are no review comments. I suspect it was not sent out. I am also unable to directly contact the editor. How can I find the editor corresponding to my article and their contact information for this journal?
(0) 讚! | 黑山天韵

作者: 潜龙丝萝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-16 13:46:56 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0 | Impact factor: 3.2
Emphasized research direction: breast cancer; Clinical experience sharing: It's very fast, rejected after external review in ten days. The most frustrating part is rejection without any review comments!
(0) 讚! | 潜龙丝萝

作者: 一阳寒梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-15 18:41:55 評論於
Too expensive, 3190 US dollars
(0) 讚! | 一阳寒梅

作者: 是巧丽吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-30 13:49:54 評論於
Research focus: clinical; breast cancer
Experience sharing: As fast as rejecting the article in just one day
(0) 讚! | 是巧丽吖

作者: Tabitha Marshall


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-27 14:40:10 評論於
It's very confusing. Submitted in August 2021, revised in September, first revision in early October, minor revisions in February 2022, and revised again the next day. Rejected on March 28, 2022, and every time it's revised, a new reviewer is assigned. I really can't believe it. The reasons for rejection are also very confusing
(0) 讚! | Tabitha Marshall

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:49:20 評論於
You may choose not to include it, but you should provide strong reasons to convince the reviewers and editors
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:14:46 評論於
All questions must be answered thoroughly without any omissions
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 12:03:58 評論於
Reviewers and journal editors are asking me to supplement experiments, do I have to supplement them all the time?
(0) 讚! | 八坂篷蔚

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 09:25:41 評論於
Do we need to respond to the reviewer's positive comments as well?
(0) 讚! | 破戒阳平

作者: 蒙德骊红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-04 15:35:06 評論於
Rejected, only one reviewer
(0) 讚! | 蒙德骊红

作者: 蒙德骊红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-10 08:45:59 評論於
Mar 9 Under Review
(0) 讚! | 蒙德骊红

作者: 一条小涵柳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-08 20:18:13 評論於
Mar 03, 2021 Submitted to Journal
Mar 03, 2021 With Editor
Mar 07, 2021 Reject
(0) 讚! | 一条小涵柳

作者: 蒙德骊红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-18 13:07:21 評論於
How long have you been under review with the editor?
(0) 讚! | 蒙德骊红

作者: 蒙德骊红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-16 17:39:29 評論於
It has been seven days with the editor, it's so slow
(0) 讚! | 蒙德骊红

作者: 墟散子冉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-18 18:34:55 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as headings
(0) 讚! | 墟散子冉

作者: Nydia Henry


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-23 15:25:23 評論於
Is there a layout fee for this? How much is it?
(0) 讚! | Nydia Henry

作者: Dylan Bright


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-26 10:30:14 評論於
Could you please translate the following paragraph into English and Japanese, using ":" and ":" as headings?
(0) 讚! | Dylan Bright

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Clinical Breast Cancer] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*